dydrogesterone has been researched along with Menopause in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 9 (37.50) | 18.2507 |
| 2000's | 3 (12.50) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cairat, M; Dossus, L; Fournier, A; Gunter, MJ; Rinaldi, S; Severi, G | 1 |
| Stute, P | 1 |
| Panay, N; Pexman-Fieth, C; Stevenson, JC | 1 |
| Huang, Y; Lin, H; Liu, J; Liu, Y; Su, F; Wang, B | 1 |
| Dasque, E; Démolis, JL; Elalamy, I; Gerotziafas, G; Lacut, K; Libersa, C; Robert, A; Rousseau, A; Simon, T; Torchin, D; Zannad, F | 1 |
| Bühling, KJ; Mueck, AO; Seeger, H | 1 |
| Borowiecka, M; Nowak, P; Połać, I; Wilamowska, A | 1 |
| Morsman, J; Varma, TR | 1 |
| Barri, PN; Carreras, O; Manubens, M; Martinez, F; Tur, R | 1 |
| D'Antona, D; De Leo, V; De Palma, P; Lanzetta, D | 1 |
| Dain, MP; MacCarthy, K; Studd, JW; Zamblera, D | 1 |
| Crook, D; Godsland, IF; Hull, J; Stevenson, JC | 1 |
| Abu-Musa, A; Hannoun, A; Karam, K; Khalil, A; Masaad, Z | 1 |
| Gruber, D; Huber, JC; Nagele, F; Sator, MO; Sator, P; Travica, S | 1 |
| van Seumeren, I | 1 |
| Barentsen, R; Kenemans, P; Scholten, PC; van de Weijer, PH; van der Mooren, MJ | 1 |
| Demacker, PN; Rolland, R; Thomas, CM; van der Mooren, MJ | 1 |
| Endacott, J; Fraser, D; Jesinger, DK; Prescott, P; Pryse-Davies, J; Siddle, NC; Whitehead, MI | 1 |
| Jesinger, DK; Lewis, B; Prescott, P; Siddle, NC; Turner, P; Whitehead, MI | 1 |
| Alazzawi, F; Dagen, MM; Farish, E; Fletcher, CD; Hart, DM; McQueen, D | 1 |
| King, RJ; Whitehead, MI | 1 |
| Varma, TR | 1 |
| King, RJ; Lane, G; Pryse-Davies, J; Ryder, TA; Siddle, NC; Whitehead, MI | 1 |
| Buytaert, P; De Cleyn, K; Delbeke, L; Gerris, J | 1 |
4 review(s) available for dydrogesterone and Menopause
| Article | Year |
|---|---|
Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
Topics: Abortion, Habitual; Abortion, Threatened; Adult; Dydrogesterone; Dysmenorrhea; Embryo Transfer; Evidence-Based Medicine; Female; Hormone Replacement Therapy; Humans; Luteal Phase; Menopause; Menstruation Disturbances; Pregnancy; Pregnancy Rate; Premenstrual Syndrome; Progestins; Reproductive Techniques, Assisted | 2021 |
Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safety.
Topics: Blood Glucose; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipid Metabolism; Menopause; Osteoporosis, Postmenopausal; Progestins | 2013 |
Use of dydrogesterone in hormone replacement therapy.
Topics: Breast Neoplasms; Cardiovascular Diseases; Drug Therapy, Combination; Dydrogesterone; Endometrial Hyperplasia; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Progestins | 2009 |
Weight gain and hormone replacement therapy: are women's fears justified?
Topics: Adult; Animals; Dydrogesterone; Estradiol; Fat Body; Female; Hormone Replacement Therapy; Humans; Longitudinal Studies; Menopause; Middle Aged; Patient Compliance; Risk Factors; Weight Gain | 2000 |
7 trial(s) available for dydrogesterone and Menopause
| Article | Year |
|---|---|
Effect of two oral doses of 17beta-estradiol associated with dydrogesterone on thrombin generation in healthy menopausal women: a randomized double-blind placebo-controlled study.
Topics: Administration, Oral; Aged; Blood Coagulation Factors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogens; Female; Humans; Menopause; Middle Aged; Progestins; Thrombin; Time Factors | 2010 |
Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.
Topics: Administration, Oral; Blood Coagulation; Cardiovascular Diseases; Drug Combinations; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinolysis; Humans; Menopause; Middle Aged; Norethindrone; Poland; Postmenopause; Progestins; Risk Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Transdermal estrogen replacement therapy in normal perimenopausal women: effects on pituitary-ovarian function.
Topics: Administration, Cutaneous; Adult; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Ovary; Pituitary Gland | 1996 |
Efficacy and safety of Menorest (50 mikrog/day) compared to Premarin 0.625 mg in the treatment of menopausal symptoms and the prevention of bone loss, in menopausal women. A single-center, comparative, randomized, double-blind, double-dummy study.
Topics: Bone Density; Double-Blind Method; Dydrogesterone; Estradiol; Estrogens, Conjugated (USP); Female; Flushing; Humans; Menopause; Osteoporosis, Postmenopausal; Pilot Projects | 1996 |
Bleeding patterns and endometrial histology during administration of low-dose estradiol sequentially combined with dydrogesterone.
Topics: Biopsy; Cross-Sectional Studies; Dydrogesterone; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hyperplasia; Menopause; Middle Aged; Uterine Hemorrhage | 1999 |
Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone.
Topics: Affective Symptoms; Anxiety; Depression; Dydrogesterone; Endometrium; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Menopause; Middle Aged | 1990 |
Effect on plasma lipids and lipoproteins of postmenopausal oestrogen therapy with added dydrogesterone.
Topics: Dydrogesterone; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Lipids; Lipoproteins; Lipoproteins, LDL; Menopause; Middle Aged; Prospective Studies | 1990 |
13 other study(ies) available for dydrogesterone and Menopause
| Article | Year |
|---|---|
Use of menopausal hormone therapy and ovarian cancer risk in a French cohort study.
Topics: Cohort Studies; Dydrogesterone; Estrogens; Female; Humans; Menopause; Ovarian Neoplasms; Postmenopause; Progesterone; Progestins; Prospective Studies; Risk Factors | 2023 |
Cognitive effects of long-term dydrogesterone treatment used alone or with estrogen on rat menopausal models of different ages.
Topics: Aging; Animals; Body Weight; Cognition; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hyperplasia; Mammary Glands, Animal; Menopause; Organ Size; Ovariectomy; Progestins; Spatial Learning; Spatial Memory; Uterus | 2015 |
Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
Topics: Adult; Aged; Cholesterol; Clonidine; Dydrogesterone; Estradiol; Estradiol Congeners; Estrogens, Conjugated (USP); Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Triglycerides | 1982 |
Ovarian function during hormonal replacement therapy in perimenopausal women.
Topics: Administration, Oral; Drug Implants; Dydrogesterone; Estrogen Replacement Therapy; Estrogens; Female; Humans; Menopause; Middle Aged; Ovary; Ovulation; Time Factors; Ultrasonography | 1993 |
Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up.
Topics: Adult; Apolipoproteins; Blood Glucose; Cholesterol; Dydrogesterone; Estradiol; Female; Follow-Up Studies; Glucose Tolerance Test; Humans; Insulin; Lipids; Lipoproteins; Menopause; Middle Aged; Prospective Studies | 1997 |
Artificial endometrial preparation for oocyte donation using synthetic estrogen and progestogen.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Dydrogesterone; Embryo Transfer; Endometrium; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Menopause; Menotropins; Oocyte Donation; Ovarian Follicle; Pregnancy; Primary Ovarian Insufficiency; Progesterone Congeners; Ultrasonography | 1998 |
Clinical profile of a new hormone replacement therapy containing 2 mg 17 beta-estradiol and 10 mg dydrogesterone.
Topics: Adult; Austria; Drug Therapy, Combination; Dydrogesterone; Estradiol; Female; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Patient Acceptance of Health Care; Prospective Studies | 2000 |
Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study.
Topics: Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Follicle Stimulating Hormone; Humans; Lipoprotein(a); Lipoproteins; Luteinizing Hormone; Menopause; Middle Aged; Prospective Studies; Triglycerides | 1992 |
The effects of conjugated equine estrogens plus cyclical dydrogesterone on serum lipoproteins and apoproteins in postmenopausal women.
Topics: Apoproteins; Drug Therapy, Combination; Dydrogesterone; Estrogens, Conjugated (USP); Female; Humans; Lipoproteins; Menopause; Middle Aged | 1988 |
Assessment of the potency of orally administered progestins in women.
Topics: Administration, Oral; Adult; Age Factors; DNA; Dose-Response Relationship, Drug; Drug Evaluation; Dydrogesterone; Endometrium; Estradiol Dehydrogenases; Female; Glycogen; Humans; Isocitrate Dehydrogenase; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Menstrual Cycle; Middle Aged; Norethindrone; Norgestrel; Progesterone; Progesterone Congeners; Reference Values | 1986 |
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
Effects of dydrogesterone on the oestrogenized postmenopausal endometrium.
Topics: Cell Nucleus; DNA; Dose-Response Relationship, Drug; Dydrogesterone; Endometrial Hyperplasia; Endometrium; Epithelium; Estrogens, Conjugated (USP); Female; Humans; Menopause; Microscopy, Electron; Receptors, Estradiol | 1986 |
Equine estrogen-dydrogesterone therapy in the management of postmenopausal women.
Topics: Drug Therapy, Combination; Dydrogesterone; Estrogens; Female; Humans; Lipids; Lipoproteins; Menopause; Middle Aged; Prospective Studies | 1986 |